Atorvastatin accelerates Mycobacterium tuberculosis clearance in pulmonary TB: a randomised phase IIA trial

Int J Tuberc Lung Dis. 2023 Mar 1;27(3):226-228. doi: 10.5588/ijtld.22.0548.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Atorvastatin / adverse effects
  • Humans
  • Mycobacterium tuberculosis*
  • Tuberculosis, Pulmonary* / drug therapy

Substances

  • Atorvastatin